HU201933B - Process for producing new spiro(14-1,4-benzodiazepine-3,4'-piperidine) derivatives and pharmaceutical compositions comprising same - Google Patents
Process for producing new spiro(14-1,4-benzodiazepine-3,4'-piperidine) derivatives and pharmaceutical compositions comprising same Download PDFInfo
- Publication number
- HU201933B HU201933B HU853222A HU322285A HU201933B HU 201933 B HU201933 B HU 201933B HU 853222 A HU853222 A HU 853222A HU 322285 A HU322285 A HU 322285A HU 201933 B HU201933 B HU 201933B
- Authority
- HU
- Hungary
- Prior art keywords
- formula
- alkyl
- benzodiazepine
- spiro
- compound
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 11
- 125000003003 spiro group Chemical group 0.000 title claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 4
- 239000002253 acid Substances 0.000 claims abstract description 24
- 238000002360 preparation method Methods 0.000 claims abstract description 10
- 150000003839 salts Chemical class 0.000 claims abstract description 7
- 150000001875 compounds Chemical class 0.000 claims description 67
- 239000001257 hydrogen Substances 0.000 claims description 22
- 229910052739 hydrogen Inorganic materials 0.000 claims description 22
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 14
- 125000006239 protecting group Chemical group 0.000 claims description 14
- 239000004480 active ingredient Substances 0.000 claims description 13
- 125000000217 alkyl group Chemical group 0.000 claims description 11
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 8
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 claims description 6
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 5
- 150000002431 hydrogen Chemical class 0.000 claims description 5
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 5
- FUFZNHHSSMCXCZ-UHFFFAOYSA-N 5-piperidin-4-yl-3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole Chemical compound FC(F)(F)C1=CC=CC(C=2N=C(ON=2)C2CCNCC2)=C1 FUFZNHHSSMCXCZ-UHFFFAOYSA-N 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- 125000002541 furyl group Chemical group 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 125000004076 pyridyl group Chemical group 0.000 claims description 2
- 125000000335 thiazolyl group Chemical group 0.000 claims description 2
- 125000001544 thienyl group Chemical group 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical group NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims 1
- 239000012050 conventional carrier Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000003379 elimination reaction Methods 0.000 claims 1
- 230000002195 synergetic effect Effects 0.000 claims 1
- 238000011282 treatment Methods 0.000 abstract description 7
- 150000001557 benzodiazepines Chemical class 0.000 abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 208000000044 Amnesia Diseases 0.000 abstract description 2
- 229940049706 benzodiazepine Drugs 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000031091 Amnestic disease Diseases 0.000 abstract 1
- 208000018152 Cerebral disease Diseases 0.000 abstract 1
- 230000006986 amnesia Effects 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 108
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 60
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 51
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 38
- 239000000203 mixture Substances 0.000 description 33
- 239000000243 solution Substances 0.000 description 32
- 239000000047 product Substances 0.000 description 27
- -1 triethylamine Chemical class 0.000 description 23
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical class NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 20
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 239000002904 solvent Substances 0.000 description 18
- 239000002585 base Substances 0.000 description 15
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 11
- 239000003208 petroleum Substances 0.000 description 11
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 10
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 8
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- 230000029936 alkylation Effects 0.000 description 8
- 238000005804 alkylation reaction Methods 0.000 description 8
- 239000013078 crystal Substances 0.000 description 8
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 229960000583 acetic acid Drugs 0.000 description 7
- 239000003463 adsorbent Substances 0.000 description 7
- 239000000908 ammonium hydroxide Substances 0.000 description 7
- 239000012362 glacial acetic acid Substances 0.000 description 7
- 239000011541 reaction mixture Substances 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 238000004440 column chromatography Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 239000000969 carrier Substances 0.000 description 5
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- UAPJXCZSNCQLMR-UHFFFAOYSA-N 4-amino-1-benzylpiperidin-1-ium-4-carboxylate Chemical compound C1CC(N)(C(O)=O)CCN1CC1=CC=CC=C1 UAPJXCZSNCQLMR-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 4
- 239000008298 dragée Substances 0.000 description 4
- 238000005984 hydrogenation reaction Methods 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- 229910052697 platinum Inorganic materials 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 239000012312 sodium hydride Substances 0.000 description 4
- 229910000104 sodium hydride Inorganic materials 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- HOIDHMTWECEBAF-UHFFFAOYSA-N 1'-benzyl-7-chloro-5-phenylspiro[1h-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound N1=C(C=2C=CC=CC=2)C2=CC(Cl)=CC=C2NC(=O)C1(CC1)CCN1CC1=CC=CC=C1 HOIDHMTWECEBAF-UHFFFAOYSA-N 0.000 description 3
- PLPMGHXRBOJVHR-UHFFFAOYSA-N 4-amino-1-benzylpiperidine-4-carbonyl chloride;dihydrochloride Chemical compound Cl.Cl.C1CC(N)(C(Cl)=O)CCN1CC1=CC=CC=C1 PLPMGHXRBOJVHR-UHFFFAOYSA-N 0.000 description 3
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 229940053197 benzodiazepine derivative antiepileptics Drugs 0.000 description 3
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 150000007529 inorganic bases Chemical class 0.000 description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 3
- 239000000155 melt Substances 0.000 description 3
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 3
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 238000007363 ring formation reaction Methods 0.000 description 3
- 239000000829 suppository Substances 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 2
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 2
- 125000006305 3-iodophenyl group Chemical group [H]C1=C([H])C(I)=C([H])C(*)=C1[H] 0.000 description 2
- WDLSJVRXVPVVAL-UHFFFAOYSA-N 7-chloro-1-methyl-5-phenylspiro[1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound O=C1N(C)C2=CC=C(Cl)C=C2C(C=2C=CC=CC=2)=NC21CCNCC2 WDLSJVRXVPVVAL-UHFFFAOYSA-N 0.000 description 2
- ZJIIWKMQNNHOCS-UHFFFAOYSA-N 7-chloro-5-phenylspiro[1h-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound N1=C(C=2C=CC=CC=2)C2=CC(Cl)=CC=C2NC(=O)C21CCNCC2 ZJIIWKMQNNHOCS-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 208000026139 Memory disease Diseases 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- 229940051881 anilide analgesics and antipyretics Drugs 0.000 description 2
- 150000003931 anilides Chemical class 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000003542 behavioural effect Effects 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 2
- 150000001805 chlorine compounds Chemical class 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000010511 deprotection reaction Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 229960002061 ergocalciferol Drugs 0.000 description 2
- LBAQSKZHMLAFHH-UHFFFAOYSA-N ethoxyethane;hydron;chloride Chemical compound Cl.CCOCC LBAQSKZHMLAFHH-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 230000000971 hippocampal effect Effects 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000002808 molecular sieve Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 2
- 235000001892 vitamin D2 Nutrition 0.000 description 2
- 239000011653 vitamin D2 Substances 0.000 description 2
- 238000010626 work up procedure Methods 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- HIRDYLVKLLGUTQ-UHFFFAOYSA-N (2-amino-4-chlorophenyl)-(2-chlorophenyl)methanone Chemical compound NC1=CC(Cl)=CC=C1C(=O)C1=CC=CC=C1Cl HIRDYLVKLLGUTQ-UHFFFAOYSA-N 0.000 description 1
- OBXGOBSNRWWAOU-UHFFFAOYSA-N (2-amino-4-chlorophenyl)-(2-fluorophenyl)methanone Chemical compound NC1=CC(Cl)=CC=C1C(=O)C1=CC=CC=C1F OBXGOBSNRWWAOU-UHFFFAOYSA-N 0.000 description 1
- IEGTYWQMAKPTBA-UHFFFAOYSA-N (2-amino-4-chlorophenyl)-(4-chlorophenyl)methanone Chemical compound NC1=CC(Cl)=CC=C1C(=O)C1=CC=C(Cl)C=C1 IEGTYWQMAKPTBA-UHFFFAOYSA-N 0.000 description 1
- YINYAGBOKBLJHY-UHFFFAOYSA-N (2-amino-4-methylphenyl)-phenylmethanone Chemical compound NC1=CC(C)=CC=C1C(=O)C1=CC=CC=C1 YINYAGBOKBLJHY-UHFFFAOYSA-N 0.000 description 1
- LXJVUGANBDAASB-UHFFFAOYSA-N (2-amino-5-bromophenyl)-phenylmethanone Chemical compound NC1=CC=C(Br)C=C1C(=O)C1=CC=CC=C1 LXJVUGANBDAASB-UHFFFAOYSA-N 0.000 description 1
- IGKULTGCASZXCT-UHFFFAOYSA-N (2-amino-5-chlorophenyl)-(1,3-thiazol-2-yl)methanone Chemical compound NC1=CC=C(Cl)C=C1C(=O)C1=NC=CS1 IGKULTGCASZXCT-UHFFFAOYSA-N 0.000 description 1
- JBKFVAVNIDDFFD-UHFFFAOYSA-N (2-amino-5-chlorophenyl)-(4-chlorophenyl)methanone Chemical compound NC1=CC=C(Cl)C=C1C(=O)C1=CC=C(Cl)C=C1 JBKFVAVNIDDFFD-UHFFFAOYSA-N 0.000 description 1
- OXZKFTFVOCOOMQ-UHFFFAOYSA-N (2-amino-5-chlorophenyl)-(furan-2-yl)methanone Chemical compound NC1=CC=C(Cl)C=C1C(=O)C1=CC=CO1 OXZKFTFVOCOOMQ-UHFFFAOYSA-N 0.000 description 1
- NRAJMXHXQHCBHO-UHFFFAOYSA-N (2-aminophenyl)-(2-fluorophenyl)methanone Chemical compound NC1=CC=CC=C1C(=O)C1=CC=CC=C1F NRAJMXHXQHCBHO-UHFFFAOYSA-N 0.000 description 1
- RMMJUQSANCPTMV-UHFFFAOYSA-N (2-aminophenyl)-(4-methylphenyl)methanone Chemical compound C1=CC(C)=CC=C1C(=O)C1=CC=CC=C1N RMMJUQSANCPTMV-UHFFFAOYSA-N 0.000 description 1
- MAOBFOXLCJIFLV-UHFFFAOYSA-N (2-aminophenyl)-phenylmethanone Chemical compound NC1=CC=CC=C1C(=O)C1=CC=CC=C1 MAOBFOXLCJIFLV-UHFFFAOYSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- VCHUSSGUGZUNQO-UHFFFAOYSA-N 1'-benzyl-5-(2-fluorophenyl)spiro[1h-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound FC1=CC=CC=C1C(C1=CC=CC=C1NC1=O)=NC11CCN(CC=2C=CC=CC=2)CC1 VCHUSSGUGZUNQO-UHFFFAOYSA-N 0.000 description 1
- RDOYGLHFCFCLLM-UHFFFAOYSA-N 1'-benzyl-5-(4-methylphenyl)spiro[1h-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound C1=CC(C)=CC=C1C(C1=CC=CC=C1NC1=O)=NC11CCN(CC=2C=CC=CC=2)CC1 RDOYGLHFCFCLLM-UHFFFAOYSA-N 0.000 description 1
- GPPPLZPPFDPJPB-UHFFFAOYSA-N 1'-benzyl-5-butyl-7-chlorospiro[1H-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound O=C1NC2=CC=C(Cl)C=C2C(CCCC)=NC1(CC1)CCN1CC1=CC=CC=C1 GPPPLZPPFDPJPB-UHFFFAOYSA-N 0.000 description 1
- OIHCPMHJUCEIBG-UHFFFAOYSA-N 1'-benzyl-5-methylspiro[1H-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound O=C1NC2=CC=CC=C2C(C)=NC1(CC1)CCN1CC1=CC=CC=C1 OIHCPMHJUCEIBG-UHFFFAOYSA-N 0.000 description 1
- ZYAIVTODSRPEJF-UHFFFAOYSA-N 1'-benzyl-5-phenyl-7-(trifluoromethyl)spiro[1h-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound N1=C(C=2C=CC=CC=2)C2=CC(C(F)(F)F)=CC=C2NC(=O)C1(CC1)CCN1CC1=CC=CC=C1 ZYAIVTODSRPEJF-UHFFFAOYSA-N 0.000 description 1
- IMZDNJUDBBQYHH-UHFFFAOYSA-N 1'-benzyl-5-phenylspiro[1h-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound O=C1NC2=CC=CC=C2C(C=2C=CC=CC=2)=NC1(CC1)CCN1CC1=CC=CC=C1 IMZDNJUDBBQYHH-UHFFFAOYSA-N 0.000 description 1
- UMPFWXKTYANUAO-UHFFFAOYSA-N 1'-benzyl-7-chloro-1-methyl-5-phenylspiro[1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound O=C1N(C)C2=CC=C(Cl)C=C2C(C=2C=CC=CC=2)=NC1(CC1)CCN1CC1=CC=CC=C1 UMPFWXKTYANUAO-UHFFFAOYSA-N 0.000 description 1
- DJTCTTJGIFJHHD-UHFFFAOYSA-N 1'-benzyl-7-chloro-5-(2-chlorophenyl)spiro[1h-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound N1=C(C=2C(=CC=CC=2)Cl)C2=CC(Cl)=CC=C2NC(=O)C1(CC1)CCN1CC1=CC=CC=C1 DJTCTTJGIFJHHD-UHFFFAOYSA-N 0.000 description 1
- ALXPLBGMPIMXDW-UHFFFAOYSA-N 1'-benzyl-7-chloro-5-(2-fluorophenyl)spiro[1h-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound FC1=CC=CC=C1C(C1=CC(Cl)=CC=C1NC1=O)=NC11CCN(CC=2C=CC=CC=2)CC1 ALXPLBGMPIMXDW-UHFFFAOYSA-N 0.000 description 1
- AJSZCJYOEGCKQB-UHFFFAOYSA-N 1'-benzyl-7-chloro-5-(4-chlorophenyl)spiro[1h-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound C1=CC(Cl)=CC=C1C(C1=CC(Cl)=CC=C1NC1=O)=NC11CCN(CC=2C=CC=CC=2)CC1 AJSZCJYOEGCKQB-UHFFFAOYSA-N 0.000 description 1
- SSWPTQZGUBAQEY-UHFFFAOYSA-N 1'-benzyl-7-chloro-5-propan-2-ylspiro[1H-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound O=C1NC2=CC=C(Cl)C=C2C(C(C)C)=NC1(CC1)CCN1CC1=CC=CC=C1 SSWPTQZGUBAQEY-UHFFFAOYSA-N 0.000 description 1
- BFMDRUHHJWUDSZ-UHFFFAOYSA-N 1'-benzyl-7-chloro-5-pyridin-2-ylspiro[1h-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound N1=C(C=2N=CC=CC=2)C2=CC(Cl)=CC=C2NC(=O)C1(CC1)CCN1CC1=CC=CC=C1 BFMDRUHHJWUDSZ-UHFFFAOYSA-N 0.000 description 1
- YEDCPLQQEWPAHI-UHFFFAOYSA-N 1'-benzyl-7-nitro-5-phenylspiro[1h-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound N1=C(C=2C=CC=CC=2)C2=CC([N+](=O)[O-])=CC=C2NC(=O)C1(CC1)CCN1CC1=CC=CC=C1 YEDCPLQQEWPAHI-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
- NMOOUZXDILJIGY-UHFFFAOYSA-N 1-(2-amino-5-chlorophenyl)-2-methylpropan-1-one Chemical compound CC(C)C(=O)C1=CC(Cl)=CC=C1N NMOOUZXDILJIGY-UHFFFAOYSA-N 0.000 description 1
- AQBCDAORSNHFNR-UHFFFAOYSA-N 1-(2-amino-5-chlorophenyl)ethanone Chemical compound CC(=O)C1=CC(Cl)=CC=C1N AQBCDAORSNHFNR-UHFFFAOYSA-N 0.000 description 1
- OOLZPYIAYOACFI-UHFFFAOYSA-N 1-(2-amino-5-chlorophenyl)pentan-1-one Chemical compound CCCCC(=O)C1=CC(Cl)=CC=C1N OOLZPYIAYOACFI-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- HEQOJEGTZCTHCF-UHFFFAOYSA-N 2-amino-1-phenylethanone Chemical compound NCC(=O)C1=CC=CC=C1 HEQOJEGTZCTHCF-UHFFFAOYSA-N 0.000 description 1
- 125000003541 2-chlorobenzoyl group Chemical group ClC1=C(C(=O)*)C=CC=C1 0.000 description 1
- 125000004847 2-fluorobenzyl group Chemical group [H]C1=C([H])C(F)=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- JNODDICFTDYODH-UHFFFAOYSA-N 2-hydroxytetrahydrofuran Chemical compound OC1CCCO1 JNODDICFTDYODH-UHFFFAOYSA-N 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000000242 4-chlorobenzoyl group Chemical group ClC1=CC=C(C(=O)*)C=C1 0.000 description 1
- 125000000590 4-methylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- JCFZXAZSJPKVDX-UHFFFAOYSA-N 5-(2-fluorophenyl)spiro[1h-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound FC1=CC=CC=C1C(C1=CC=CC=C1NC1=O)=NC11CCNCC1 JCFZXAZSJPKVDX-UHFFFAOYSA-N 0.000 description 1
- PMBBVHKRYCZROF-UHFFFAOYSA-N 5-(4-methylphenyl)spiro[1h-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound C1=CC(C)=CC=C1C(C1=CC=CC=C1NC1=O)=NC11CCNCC1 PMBBVHKRYCZROF-UHFFFAOYSA-N 0.000 description 1
- VNQZPPMIXURQBM-UHFFFAOYSA-N 5-butyl-7-chlorospiro[1H-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound O=C1NC2=CC=C(Cl)C=C2C(CCCC)=NC21CCNCC2 VNQZPPMIXURQBM-UHFFFAOYSA-N 0.000 description 1
- GMBRPBXIEBLHGT-UHFFFAOYSA-N 5-methylspiro[1H-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound O=C1NC2=CC=CC=C2C(C)=NC21CCNCC2 GMBRPBXIEBLHGT-UHFFFAOYSA-N 0.000 description 1
- JWPBAOXOBNYIRH-UHFFFAOYSA-N 5-phenyl-7-(trifluoromethyl)spiro[1h-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound N1=C(C=2C=CC=CC=2)C2=CC(C(F)(F)F)=CC=C2NC(=O)C21CCNCC2 JWPBAOXOBNYIRH-UHFFFAOYSA-N 0.000 description 1
- DULSJKXBUGUHOI-UHFFFAOYSA-N 7-chloro-1',4-dimethyl-5-phenylspiro[1,5-dihydro-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound C1CN(C)CCC21C(=O)NC1=CC=C(Cl)C=C1C(C=1C=CC=CC=1)N2C DULSJKXBUGUHOI-UHFFFAOYSA-N 0.000 description 1
- SFGCCFUULMZVND-UHFFFAOYSA-N 7-chloro-1'-methyl-5-phenylspiro[1h-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound C1CN(C)CCC21C(=O)NC1=CC=C(Cl)C=C1C(C=1C=CC=CC=1)=N2 SFGCCFUULMZVND-UHFFFAOYSA-N 0.000 description 1
- XZVJCGGZWONZPI-UHFFFAOYSA-N 7-chloro-1'-methyl-5-phenylspiro[1h-1,4-benzodiazepine-3,4'-piperidine]-2-one;hydrochloride Chemical compound Cl.C1CN(C)CCC21C(=O)NC1=CC=C(Cl)C=C1C(C=1C=CC=CC=1)=N2 XZVJCGGZWONZPI-UHFFFAOYSA-N 0.000 description 1
- BBZDURHUDVJOMJ-UHFFFAOYSA-N 7-chloro-1'-methyl-5-phenylspiro[4,5-dihydro-1h-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound C1CN(C)CCC21C(=O)NC1=CC=C(Cl)C=C1C(C=1C=CC=CC=1)N2 BBZDURHUDVJOMJ-UHFFFAOYSA-N 0.000 description 1
- HUZLOWKVQBKMCB-UHFFFAOYSA-N 7-chloro-1,1',4-trimethyl-5-phenylspiro[5h-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound C1CN(C)CCC21C(=O)N(C)C1=CC=C(Cl)C=C1C(C=1C=CC=CC=1)N2C HUZLOWKVQBKMCB-UHFFFAOYSA-N 0.000 description 1
- DNTOCGRDWRDLQX-UHFFFAOYSA-N 7-chloro-1,1'-dimethyl-5-phenylspiro[4,5-dihydro-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound C1CN(C)CCC21C(=O)N(C)C1=CC=C(Cl)C=C1C(C=1C=CC=CC=1)N2 DNTOCGRDWRDLQX-UHFFFAOYSA-N 0.000 description 1
- SNDJRSZRKKWXNY-UHFFFAOYSA-N 7-chloro-1,1'-dimethyl-5-phenylspiro[4,5-dihydro-2H-1,4-benzodiazepine-3,4'-piperidine] Chemical compound ClC=1C=CC2=C(C(NC3(CCN(CC3)C)CN2C)C2=CC=CC=C2)C=1 SNDJRSZRKKWXNY-UHFFFAOYSA-N 0.000 description 1
- JURRMHKKFIRUAH-UHFFFAOYSA-N 7-chloro-1-ethyl-5-phenylspiro[1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound O=C1N(CC)C2=CC=C(Cl)C=C2C(C=2C=CC=CC=2)=NC21CCNCC2 JURRMHKKFIRUAH-UHFFFAOYSA-N 0.000 description 1
- JHLASPMQEQHGJC-UHFFFAOYSA-N 7-chloro-1-ethyl-5-phenylspiro[4,5-dihydro-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound O=C1N(CC)C2=CC=C(Cl)C=C2C(C=2C=CC=CC=2)NC21CCNCC2 JHLASPMQEQHGJC-UHFFFAOYSA-N 0.000 description 1
- BQGVOJSNOVSCHG-UHFFFAOYSA-N 7-chloro-5-(1,3-thiazol-2-yl)spiro[1h-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound N1=C(C=2SC=CN=2)C2=CC(Cl)=CC=C2NC(=O)C21CCNCC2 BQGVOJSNOVSCHG-UHFFFAOYSA-N 0.000 description 1
- TVRINUOGXXXYJR-UHFFFAOYSA-N 7-chloro-5-(2-chlorophenyl)spiro[1h-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound N1=C(C=2C(=CC=CC=2)Cl)C2=CC(Cl)=CC=C2NC(=O)C21CCNCC2 TVRINUOGXXXYJR-UHFFFAOYSA-N 0.000 description 1
- YHHHBLHRHJCABO-UHFFFAOYSA-N 7-chloro-5-(2-fluorophenyl)spiro[1h-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound FC1=CC=CC=C1C(C1=CC(Cl)=CC=C1NC1=O)=NC11CCNCC1 YHHHBLHRHJCABO-UHFFFAOYSA-N 0.000 description 1
- CEMUEYVBHJCYLJ-UHFFFAOYSA-N 7-chloro-5-(3-iodophenyl)spiro[1h-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound N1=C(C=2C=C(I)C=CC=2)C2=CC(Cl)=CC=C2NC(=O)C21CCNCC2 CEMUEYVBHJCYLJ-UHFFFAOYSA-N 0.000 description 1
- QTPVZFGWJUNOMF-UHFFFAOYSA-N 7-chloro-5-(4-chlorophenyl)spiro[1h-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound C1=CC(Cl)=CC=C1C(C1=CC(Cl)=CC=C1NC1=O)=NC11CCNCC1 QTPVZFGWJUNOMF-UHFFFAOYSA-N 0.000 description 1
- QQPCFVCLNBMWNS-UHFFFAOYSA-N 7-chloro-5-(furan-2-yl)spiro[1h-1,4-benzodiazepine-3,4'-piperidine]-2-one Chemical compound N1=C(C=2OC=CC=2)C2=CC(Cl)=CC=C2NC(=O)C21CCNCC2 QQPCFVCLNBMWNS-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 206010051290 Central nervous system lesion Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 102000004300 GABA-A Receptors Human genes 0.000 description 1
- 108090000839 GABA-A Receptors Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 208000020358 Learning disease Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 238000000585 Mann–Whitney U test Methods 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 229910020889 NaBH3 Inorganic materials 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- GMZVRMREEHBGGF-UHFFFAOYSA-N Piracetam Chemical compound NC(=O)CN1CCCC1=O GMZVRMREEHBGGF-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- NRMOBHGSHDKJLW-UHFFFAOYSA-N [2-amino-5-(trifluoromethyl)phenyl]-phenylmethanone Chemical compound NC1=CC=C(C(F)(F)F)C=C1C(=O)C1=CC=CC=C1 NRMOBHGSHDKJLW-UHFFFAOYSA-N 0.000 description 1
- 239000003655 absorption accelerator Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 238000010976 amide bond formation reaction Methods 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 230000000949 anxiolytic effect Effects 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical class C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- UYVSMWAWZVBQJM-UHFFFAOYSA-N benzyl 5-butyl-7-chloro-2-oxospiro[1H-1,4-benzodiazepine-3,4'-piperidine]-1'-carboxylate Chemical compound ClC=1C=CC2=C(C(=NC3(CCN(CC3)C(=O)OCC3=CC=CC=C3)C(N2)=O)CCCC)C=1 UYVSMWAWZVBQJM-UHFFFAOYSA-N 0.000 description 1
- YHSCBISJHXGQLX-UHFFFAOYSA-N benzyl 5-methyl-2-oxospiro[1H-1,4-benzodiazepine-3,4'-piperidine]-1'-carboxylate Chemical compound O=C1NC2=CC=CC=C2C(C)=NC1(CC1)CCN1C(=O)OCC1=CC=CC=C1 YHSCBISJHXGQLX-UHFFFAOYSA-N 0.000 description 1
- PEQMAELWCFWOJB-UHFFFAOYSA-N benzyl 7-bromo-2-oxo-5-phenylspiro[1h-1,4-benzodiazepine-3,4'-piperidine]-1'-carboxylate Chemical compound N1=C(C=2C=CC=CC=2)C2=CC(Br)=CC=C2NC(=O)C1(CC1)CCN1C(=O)OCC1=CC=CC=C1 PEQMAELWCFWOJB-UHFFFAOYSA-N 0.000 description 1
- XLPQDNNOWSYQQV-UHFFFAOYSA-N benzyl 7-chloro-2-oxo-5-phenylspiro[1,5-dihydro-1,4-benzodiazepine-3,4'-piperidine]-4-carboxylate Chemical compound C=1C=CC=CC=1COC(=O)N1C(C=2C=CC=CC=2)C2=CC(Cl)=CC=C2NC(=O)C21CCNCC2 XLPQDNNOWSYQQV-UHFFFAOYSA-N 0.000 description 1
- ZSWUMWAWGCAWOK-UHFFFAOYSA-N benzyl 7-chloro-2-oxo-5-thiophen-2-ylspiro[1h-1,4-benzodiazepine-3,4'-piperidine]-1'-carboxylate Chemical compound N1=C(C=2SC=CC=2)C2=CC(Cl)=CC=C2NC(=O)C1(CC1)CCN1C(=O)OCC1=CC=CC=C1 ZSWUMWAWGCAWOK-UHFFFAOYSA-N 0.000 description 1
- XTWVGSJFIPVYLL-UHFFFAOYSA-N benzyl 7-chloro-5-(2-chlorophenyl)-2-oxospiro[1h-1,4-benzodiazepine-3,4'-piperidine]-1'-carboxylate Chemical compound N1=C(C=2C(=CC=CC=2)Cl)C2=CC(Cl)=CC=C2NC(=O)C1(CC1)CCN1C(=O)OCC1=CC=CC=C1 XTWVGSJFIPVYLL-UHFFFAOYSA-N 0.000 description 1
- FAXYFOCNKJNGAM-UHFFFAOYSA-N benzyl 7-chloro-5-(furan-2-yl)-2-oxospiro[1h-1,4-benzodiazepine-3,4'-piperidine]-1'-carboxylate Chemical compound N1=C(C=2OC=CC=2)C2=CC(Cl)=CC=C2NC(=O)C1(CC1)CCN1C(=O)OCC1=CC=CC=C1 FAXYFOCNKJNGAM-UHFFFAOYSA-N 0.000 description 1
- REQTWLORNSVYFS-UHFFFAOYSA-N benzyl 8-methyl-2-oxospiro[1h-1,4-benzodiazepine-3,4'-piperidine]-1'-carboxylate Chemical compound O=C1NC2=CC(C)=CC=C2C=NC1(CC1)CCN1C(=O)OCC1=CC=CC=C1 REQTWLORNSVYFS-UHFFFAOYSA-N 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000005978 brain dysfunction Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- ASARMUCNOOHMLO-WLORSUFZSA-L cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2s)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O ASARMUCNOOHMLO-WLORSUFZSA-L 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 229940117389 dichlorobenzene Drugs 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- NSNHWTBQMQIDCF-UHFFFAOYSA-N dihydrate;hydrochloride Chemical compound O.O.Cl NSNHWTBQMQIDCF-UHFFFAOYSA-N 0.000 description 1
- LUZRJRNZXALNLM-JGRZULCMSA-N dihydroergotamine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2[C@@H](C=3C=CC=C4NC=C(C=34)C2)C1)C)C1=CC=CC=C1 LUZRJRNZXALNLM-JGRZULCMSA-N 0.000 description 1
- 229960004704 dihydroergotamine Drugs 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- GUTQMBQKTSGBPQ-UHFFFAOYSA-N dithiophen-2-ylmethanone Chemical compound C=1C=CSC=1C(=O)C1=CC=CS1 GUTQMBQKTSGBPQ-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- XCGSFFUVFURLIX-VFGNJEKYSA-N ergotamine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C=3C=CC=C4NC=C(C=34)C2)=C1)C)C1=CC=CC=C1 XCGSFFUVFURLIX-VFGNJEKYSA-N 0.000 description 1
- 229960004943 ergotamine Drugs 0.000 description 1
- XCGSFFUVFURLIX-UHFFFAOYSA-N ergotaminine Natural products C1=C(C=2C=CC=C3NC=C(C=23)C2)C2N(C)CC1C(=O)NC(C(N12)=O)(C)OC1(O)C1CCCN1C(=O)C2CC1=CC=CC=C1 XCGSFFUVFURLIX-UHFFFAOYSA-N 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229940093499 ethyl acetate Drugs 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- DKAGJZJALZXOOV-UHFFFAOYSA-N hydrate;hydrochloride Chemical compound O.Cl DKAGJZJALZXOOV-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 201000003723 learning disability Diseases 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 230000007334 memory performance Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- RVJKIPFPMXENNO-UHFFFAOYSA-N n-(4-chlorophenyl)cyclohexanecarboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)C1CCCCC1 RVJKIPFPMXENNO-UHFFFAOYSA-N 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000002664 nootropic agent Substances 0.000 description 1
- 230000001777 nootropic effect Effects 0.000 description 1
- GTDQGKWDWVUKTI-UHFFFAOYSA-N o-aminoacetophenone Chemical compound CC(=O)C1=CC=CC=C1N GTDQGKWDWVUKTI-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 150000003053 piperidines Chemical class 0.000 description 1
- 229960004526 piracetam Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000012421 spiking Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19843431195 DE3431195A1 (de) | 1984-08-24 | 1984-08-24 | Neue benzodiazepine, verfahren zu ihrer herstellung sowie ihre verwendung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUT39449A HUT39449A (en) | 1986-09-29 |
| HU201933B true HU201933B (en) | 1991-01-28 |
Family
ID=6243820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU853222A HU201933B (en) | 1984-08-24 | 1985-08-23 | Process for producing new spiro(14-1,4-benzodiazepine-3,4'-piperidine) derivatives and pharmaceutical compositions comprising same |
Country Status (19)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4957915A (en) * | 1989-02-27 | 1990-09-18 | Biomeasure, Inc. | Benzodiazepine analogs |
| CA2160786A1 (en) * | 1993-05-14 | 1994-11-24 | James C. Marsters, Jr. | Ras farnesyl transferase inhibitors |
| CA2469879A1 (en) * | 2001-12-14 | 2003-06-26 | Merck & Co. Inc. | A novel sordarin derivative isolated from culture fermentations and functions as an antifungal agent |
| EP1591120A4 (en) * | 2003-01-28 | 2009-06-10 | Takeda Chemical Industries Ltd | RECEPTOR AGONISTS |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3998811A (en) * | 1971-03-17 | 1976-12-21 | Crc Compagnia Di Recerca Chimica S.A. | Optically active 1,4-benzodiazepines and process for the preparation thereof |
| HU171033B (hu) * | 1974-05-29 | 1977-10-28 | Richter Gedeon Vegyeszet | Sposob poluchenija proizvodnykh benzodiazepina |
| CA1157855A (en) * | 1980-07-31 | 1983-11-29 | Albert E. Fischli | Benzodiazepine derivatives |
| NL8401907A (nl) * | 1983-06-27 | 1985-01-16 | Sandoz Ag | Spirosuccinimiden en werkwijzen voor het bereiden en toepassen van deze spirosuccinimiden. |
-
1984
- 1984-08-24 DE DE19843431195 patent/DE3431195A1/de not_active Withdrawn
-
1985
- 1985-08-05 NO NO853089A patent/NO161494C/no unknown
- 1985-08-08 US US06/763,746 patent/US4647560A/en not_active Expired - Fee Related
- 1985-08-14 AT AT85110191T patent/ATE46905T1/de not_active IP Right Cessation
- 1985-08-14 EP EP85110191A patent/EP0172526B1/de not_active Expired
- 1985-08-14 DE DE8585110191T patent/DE3573425D1/de not_active Expired
- 1985-08-21 PH PH32676A patent/PH23803A/en unknown
- 1985-08-21 NZ NZ213186A patent/NZ213186A/en unknown
- 1985-08-21 IL IL76153A patent/IL76153A0/xx not_active IP Right Cessation
- 1985-08-22 CA CA000489254A patent/CA1249269A/en not_active Expired
- 1985-08-22 GR GR852035A patent/GR852035B/el unknown
- 1985-08-22 FI FI853229A patent/FI79315C/fi not_active IP Right Cessation
- 1985-08-22 AU AU46574/85A patent/AU574216B2/en not_active Ceased
- 1985-08-22 PT PT81003A patent/PT81003B/pt not_active IP Right Cessation
- 1985-08-23 HU HU853222A patent/HU201933B/hu not_active IP Right Cessation
- 1985-08-23 ZA ZA856409A patent/ZA856409B/xx unknown
- 1985-08-23 ES ES546378A patent/ES8702910A1/es not_active Expired
- 1985-08-23 KR KR1019850006080A patent/KR920000763B1/ko not_active Expired
- 1985-08-23 JP JP60184317A patent/JPS6157582A/ja active Granted
- 1985-08-23 DK DK384585A patent/DK384585A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0172526A1 (de) | 1986-02-26 |
| DK384585D0 (da) | 1985-08-23 |
| FI853229L (fi) | 1986-02-25 |
| KR920000763B1 (ko) | 1992-01-21 |
| PH23803A (en) | 1989-11-03 |
| ES8702910A1 (es) | 1987-01-16 |
| JPS6157582A (ja) | 1986-03-24 |
| GR852035B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1985-12-18 |
| PT81003A (en) | 1985-09-01 |
| ZA856409B (en) | 1986-04-30 |
| US4647560A (en) | 1987-03-03 |
| NO161494C (no) | 1989-08-23 |
| AU574216B2 (en) | 1988-06-30 |
| FI79315B (fi) | 1989-08-31 |
| DE3431195A1 (de) | 1986-03-06 |
| DE3573425D1 (en) | 1989-11-09 |
| NO853089L (no) | 1986-02-25 |
| JPH0378868B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1991-12-17 |
| PT81003B (pt) | 1987-12-30 |
| ES546378A0 (es) | 1987-01-16 |
| DK384585A (da) | 1986-02-25 |
| HUT39449A (en) | 1986-09-29 |
| EP0172526B1 (de) | 1989-10-04 |
| FI853229A0 (fi) | 1985-08-22 |
| NZ213186A (en) | 1988-04-29 |
| KR860001812A (ko) | 1986-03-22 |
| IL76153A0 (en) | 1985-12-31 |
| CA1249269A (en) | 1989-01-24 |
| FI79315C (fi) | 1989-12-11 |
| ATE46905T1 (de) | 1989-10-15 |
| AU4657485A (en) | 1986-02-27 |
| NO161494B (no) | 1989-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6069156A (en) | Indole derivatives as cGMP-PDE inhibitors | |
| JPH07509482A (ja) | ベンゾジアセピン誘導体 | |
| KR100221158B1 (ko) | 6-헤테로사이클릭-4-아미노-1,3,4,5-테트라하이드로벤즈(cd)인돌 | |
| KR20010087361A (ko) | [1,2,4]트리아졸로[1,5-ｃ]피리미딘 유도체 | |
| US5696111A (en) | 3-acylaminobenzazepines | |
| JPH09500397A (ja) | ベンゾジアゼピン類 | |
| KR0164599B1 (ko) | 피리다진 유도체 이의 제조방법 및 이것을 함유하는 약학 조성물 | |
| US5565463A (en) | 9-subtituted-8-unsubstituted-9-deazaguanines | |
| US6369057B1 (en) | Quinoxalines, processes for their preparation and their use | |
| JPH04334367A (ja) | 置換された１，２，３，４−テトラヒドロシクロペント〔ｂ〕インドール、１，２，３，３ａ，４，８ａ−ヘキサヒドロシクロペント〔ｂ〕インドールおよび関連化合物 | |
| EP0167901A2 (en) | Active compounds | |
| HU201933B (en) | Process for producing new spiro(14-1,4-benzodiazepine-3,4'-piperidine) derivatives and pharmaceutical compositions comprising same | |
| KR100485020B1 (ko) | 옥타하이드로-2Ｈ-피리도[1,2-ａ]피라진 화합물, 이들의 제조방법 및 이들을 함유하는 약제학적 조성물 | |
| JPH09500395A (ja) | ３−アシルアミノベンゾジアゼピン類 | |
| CA2513059A1 (fr) | Nouveaux derives d'azepines tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| US6063803A (en) | Octahydropyrrolo-[3,4-c]carbazoles useful as analgesic agents | |
| FI76786C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara 4-(3-trifluormetylfenyl)-1,2,3,6- tetrahydropyridiner. | |
| HU203889B (en) | Process for producing heterocyclic lactame derivatives and pharmaceutical compositions containing them as active components | |
| HU186028B (en) | Process for preparing pyrrolo-benzoidiazepines | |
| KR100255619B1 (ko) | 신규한 피페리딘 유도체 및 이의 제조방법 | |
| CA1238905A (en) | ¬1,3|oxazino¬4,3-a|-isoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them | |
| JP2001512124A (ja) | 新規な２，３−ベンゾジアゼピン誘導体 | |
| HU201944B (en) | Process for producing isoxazolazepine derivatives and pharmaceutical compositions comprising such active ingredient | |
| KR100642844B1 (ko) | 이미다졸린 화합물, 이의 제조 방법 및 이를 함유하는약제 조성물 | |
| CH651833A5 (fr) | Pyrido(1,4)benzodiazepines phenyl-substituees methanones correspondantes et medicaments les contenant. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HMM4 | Cancellation of final prot. due to non-payment of fee |